Dietary trehalose enhances virulence of epidemic Clostridium difficile J Collins, C Robinson, H Danhof, CW Knetsch, HC Van Leeuwen, ... Nature 553 (7688), 291-294, 2018 | 339 | 2018 |
Offsetting virulence and antibiotic resistance costs by MRSA J Collins, J Rudkin, M Recker, C Pozzi, JP O'gara, RC Massey The ISME journal 4 (4), 577-584, 2010 | 113 | 2010 |
Infant Colic Represents Gut Inflammation and Dysbiosis JM Rhoads, J Collins, NY Fatheree, SS Hashmi, CM Taylor, M Luo, ... The Journal of Pediatrics 203, 55-61, 2018 | 105 | 2018 |
Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates CD Robinson, JM Auchtung, J Collins, RA Britton Infection and immunity 82 (7), 2815-2825, 2014 | 95 | 2014 |
Humanized microbiota mice as a model of recurrent Clostridium difficile disease J Collins, JM Auchtung, L Schaefer, KA Eaton, RA Britton Microbiome 3, 1-15, 2015 | 77 | 2015 |
The role of trehalose in the global spread of Clostridium difficile J Collins, H Danhof, R Britton Gut Microbes 10 (2), 204-209, 2018 | 43* | 2018 |
Identification of Factors Contributing to T-Cell Toxicity of Staphylococcus aureus Clinical Isolates J Collins, A Buckling, RC Massey Journal of clinical microbiology 46 (6), 2112-2114, 2008 | 39 | 2008 |
Fibrinogen‐binding and platelet‐aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen‐binding protein J Collins, JP van Pijkeren, L Svensson, MJ Claesson, M Sturme, Y Li, ... Molecular microbiology 85 (5), 862-877, 2012 | 32 | 2012 |
Control of Clostridium difficile Infection by Defined Microbial Communities J Collins, JM Auchtung Microbiology spectrum 5 (5), 10.1128/microbiolspec. bad-0009-2016, 2017 | 30 | 2017 |
Degradation-resistant trehalose analogues block utilization of trehalose by hypervirulent Clostridioides difficile ND Danielson, J Collins, AI Stothard, QQ Dong, K Kalera, PJ Woodruff, ... Chemical communications 55 (34), 5009-5012, 2019 | 28 | 2019 |
AMiGA: Software for Automated Analysis of Microbial Growth Assays FS Midani, J Collins, RA Britton mSystems, 2021 | 27 | 2021 |
Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction JM Auchtung, EC Preisner, J Collins, AI Lerma, RA Britton mSphere 5 (e00387-20), 2020 | 20 | 2020 |
Rapid, Efficient, and Cost-Effective Gene Editing of Enterococcus faecium with CRISPR-Cas12a MJ Chua, J Collins Microbiology Spectrum, 2022 | 5 | 2022 |
Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy MB Yacyshyn, J Collins, M Chua, A Siegwald, S Yacyshyn, ... Current Therapeutic Research, Clinical and Experimental 96, 2022 | 2 | 2022 |
The microbial metabolite Urolithin A reduces C. difficile toxin expression and repairs toxin-induced epithelial damage S Ghosh, D Erickson, MJ Chua, J Collins, VR Jala bioRxiv, 2023 | | 2023 |
S3440 A Pilot Study of Oral Bismuth Subsalicylate for the Treatment of Symptoms of Acute COVID-19 (SABER-C) J Collins, MB Yacyshyn, S Yacyshyn, J Brum, V Briones-Pryor, ... Official journal of the American College of Gastroenterology| ACG 116, S1417, 2021 | | 2021 |